Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:BOLD
Tag: NASDAQ:BOLD
Audentes Therapeutics Inc (NASDAQ:BOLD) price target raised to $48.00 by HC...
ME Staff
-
April 26, 2019
0
AUDENTES THERAPEUTICS, INC. (NASDAQ:BOLD) Files An 8-K Other Events
ME Staff 8-k
-
April 8, 2019
0
Audentes Therapeutics Inc (NASDAQ:BOLD) had its Buy rating reiterated by HC...
ME Staff
-
March 18, 2019
0
Audentes Therapeutics Inc (NASDAQ:BOLD) gets upgraded to Buy by Chardan Capital...
ME Staff
-
February 25, 2019
0
Audentes Therapeutics Inc (NASDAQ:BOLD) had its Buy rating reiterated by HC...
ME Staff
-
November 7, 2018
0
Audentes Therapeutics Inc (NASDAQ:BOLD) had its Buy rating reiterated by HC...
ME Staff
-
October 8, 2018
0
Audentes Therapeutics Inc (NASDAQ:BOLD) had its Buy rating reiterated by Mizuho...
ME Staff
-
October 3, 2018
0
Audentes Therapeutics Inc (NASDAQ:BOLD) has coverage initiated with a Sell rating...
ME Staff
-
September 7, 2018
0
Audentes Therapeutics Inc (NASDAQ:BOLD) price target set to $40.00 by HC...
ME Staff
-
August 22, 2018
0
Audentes Therapeutics Inc (NASDAQ:BOLD) had its Buy rating reiterated by Mizuho...
ME Staff
-
August 22, 2018
0
1
2
3
4
Page 1 of 4
